Finance
Finance
Home688136 • SHA
Kexing Biopharm Co Ltd
ÂĄ49.95
Jul 4, 4:29:43 PM GMT+8 · CNY · SHA · Disclaimer
Stock
Previous close
ÂĄ49.00
Day range
ÂĄ46.50 - ÂĄ50.90
Year range
ÂĄ13.67 - ÂĄ63.99
Market cap
9.78B CNY
Avg Volume
6.39M
P/E ratio
224.09
Dividend yield
0.16%
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY)Mar 2025Y/Y change
Revenue
353.56M-1.97%
Operating expense
202.00M-15.12%
Net income
25.58M106.21%
Net profit margin
7.23110.17%
Earnings per share
——
EBITDA
59.50M40.77%
Effective tax rate
21.82%—
Total assets
Total liabilities
(CNY)Mar 2025Y/Y change
Cash and short-term investments
576.27M6.27%
Total assets
3.19B4.24%
Total liabilities
1.53B5.96%
Total equity
1.67B—
Shares outstanding
197.76M—
Price to book
5.82—
Return on assets
2.99%—
Return on capital
3.29%—
Net change in cash
(CNY)Mar 2025Y/Y change
Net income
25.58M106.21%
Cash from operations
25.45M508.80%
Cash from investing
-110.34M50.76%
Cash from financing
20.66M24.58%
Net change in cash
-63.78M70.07%
Free cash flow
-32.21M73.50%
About
Founded
1989
Website
Employees
947
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu